Abraham Bassan - Oct 23, 2025 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Director
Signature
/s/ Svai Sanford, Attorney-in-Fact
Stock symbol
RANI
Transactions as of
Oct 23, 2025
Transactions value $
$0
Form type
4
Date filed
10/27/2025, 07:29 PM
Previous filing
Aug 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bassan Abraham Director C/O RANI THERAPEUTICS LLC, 2051 RINGWOOD AVE., SAN JOSE /s/ Svai Sanford, Attorney-in-Fact 2025-10-27 0001864485

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RANI Stock Option (Right to Buy) Award $0 +100K $0.00 100K Oct 23, 2025 Class A Common Stock 100K $2.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest over a three-year period, with one-third of the shares subject to the option vesting on October 23, 2026, and one thirty-sixth of the shares subject to the option vesting each month thereafter, subject to the Reporting Person's continuous service with the Company through each vesting date.